Bandingkan Harga & Kinerja Indo-Rama Synthetics Tbk. (INDR) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indo-Rama Synthetics Tbk. dan Organon Pharma Indonesia Tbk.: Indo-Rama Synthetics Tbk. diperdagangkan di Rp2.960 (kapitalisasi pasar 1,99 T, volume 24 jam 83,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indo-Rama Synthetics Tbk. jauh lebih besar — sekitar 19,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INDR | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,99 T | 104,4 M |
Volume | 83,1 rb | — |
Lot | 831 | — |
Perputaran | 241,77 jt | — |
Harga Rata-rata | 2.909,43 | — |
Nilai Transaksi | 241,77 jt | — |
Harga Ekuilibrium Indikatif | 2.960 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indo-Rama Synthetics Tbk.
PT. Indo-Rama Synthetics Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial DeedNo. 21 dated April 3, 1974, of Gustaaf Hoemala Soangkoepon Loemban Tobing, SH, public notary in Jakarta.
Selengkapnya di halaman INDR →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
